The report on global tissue
diagnostic market is an in depth analysis of the segments and sub-segments in
the tissue diagnostic market. The report provides analysis for the global as
well as regional markets over the period of 2015 to 2023. According to report
the global tissue diagnostic market is expected to grow at a CAGR of 6.5% over
the forecast period of 2017 - 2023.
Figure 1: Global Tissue Diagnostic Market
by Value 2015 - 2023
The report on global tissue
diagnostic market covers segments such as product,
technology, application and end-use. The product segments include accessories
and instruments. On the basis of technology, the global tissue diagnostic
market is categorized into digital pathology and workflow, special staining, in
situ hybridization and immunohistochemistry (IHC). Furthermore, on the basis of
application the tissue diagnostic market is segmented as non-small cell lung
cancer, prostate cancer, gastric cancer, breast cancer and lymphoma. On the
basis of end-use the tissue diagnostic market is segmented as research
laboratories, pharmaceutical organizations, contract research organization (CRO)
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each
geography is provided over the period of 2015 – 2023.
Figure 2: Global Tissue Diagnostic
Market by Region, CAGR %, 2015-2023
The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific
includes China, Japan, India, South Korea and Malaysia among others. The U.S.
drives the growth in the North America region as it is the largest market in
the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The
APAC region is projected to experience a growth at a CAGR of x.x% over the
period of 2017 - 2023.
The report provides profiles of
the companies in the global tissue diagnostic market such as, Prometheus
Laboratories, bioMerieux, DiaGenic, Alere, Becton Dickinson & Company,
Qiagen, Siemens Healthcare, Johnson & Johnson, GE Healthcare, and Bio SB.
The report provides deep insights
on demand forecasts, market trends and micro and macro indicators. In addition,
this report provides insights on the factors that are driving and restraining
the global tissue diagnostic market. Moreover, IGR-Growth Matrix analysis given
in the report brings an insight on the investment areas that existing or new
market players can consider.
The report provides insights into
the market using analytical tools such as Porter’s five forces analysis and DRO
analysis of tissue diagnostic market. Moreover, the study highlights current
market trends and provides forecast from 2017 to 2023. We also have highlighted
future trends in the tissue diagnostic market that will impact the demand
during the forecast period. Moreover, the competitive analysis given in each
regional market brings an insight on the market share of the leading players.
Additionally, the analysis highlights rise and fall in the market shares of the
key players in the market.
This report will help
manufacturers, suppliers and distributors of the tissue diagnostic market to
understand the present and future trends in this market and formulate their